157 studies found for:    Open Studies | "Pharyngeal Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Pharyngeal Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy
Conditions: Pharyngeal Neoplasms;   Laryngeal Neoplasms;   Carcinoma
Interventions: Device: prothesis voice;   Procedure: total laryngectomy
2 Not yet recruiting Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy
Conditions: Dysphagia;   Oral Pharyngeal Cancer
Intervention: Device: Iowa Oral Performance Instrument
3 Unknown  Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
Conditions: Cancer of the Pharynx;   Cancer of the Larynx;   Cancer of the Neck;   Paranasal Sinus Neoplasms;   Cancer of the Head
Intervention: Drug: erlotinib + celecoxib
4 Not yet recruiting Individualized Elective Neck Irradiation Based on MRI in NPC Patients
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: Elective neck irradiation;   Radiation: Whole neck irradiation
5 Recruiting Endostar for Locally Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Endostatins;   Radiation: IMRT
6 Recruiting Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: IMRT;   Drug: Cisplatin
7 Recruiting Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cetuximab;   Drug: Cisplatin;   Drug: Docetaxel;   Drug: Capecitabine;   Radiation: Radiotherapy
8 Recruiting Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx Cancers
Condition: Oropharynx Cancers
Interventions: Other: blood draw;   Behavioral: study questionnaire;   Other: cardiopulmonary exercise testing (CPET);   Other: DXA (dual-energy x-ray absorptiometry) scan
9 Recruiting Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Radiation: IMRT using individualized CTV;   Radiation: IMRT using traditional CTV;   Drug: Gemcitabine and cisplatin (induction chemotherapy);   Drug: Docetaxel and cisplatin (induction chemotherapy);   Drug: Cisplatin 100mg/m² concurrent chemotherapy;   Drug: Cisplatin 80mg/m² concurrent chemotherapy
10 Not yet recruiting Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cisplatin 1;   Drug: Cisplatin 2;   Drug: Docetaxel;   Drug: Xeloda;   Radiation: Intensity-modulated radiotherapy
11 Not yet recruiting Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122, KEYNOTE-122)
Condition: Nasopharyngeal Neoplasms
Interventions: Biological: pembrolizumab;   Drug: capecitabine;   Drug: gemcitabine;   Drug: docetaxel
12 Recruiting Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cisplatin 2;   Drug: Docetaxel;   Drug: Cisplatin 1;   Radiation: Intensity-modulated radiotherapy
13 Recruiting Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cisplatin;   Radiation: Intensity-modulated radiotherapy
14 Not yet recruiting Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: PDR001;   Drug: Investigator choice of chemotherapy
15 Recruiting Nasopharyngeal Carcinoma Post IMRT
Condition: Nasopharyngeal Carcinoma
Intervention:
16 Recruiting A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Recombinant Human Endostatin Injection (Endostar);   Drug: Fluorouracil (5-Fu);   Drug: Nedaplatin
17 Not yet recruiting Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China
Condition: Nasopharyngeal Cancinoma (NPC)
Intervention:
18 Recruiting NBI to Detect Post-RT Mucosal Residual NPC
Condition: Nasopharyngeal Carcinoma
Intervention: Device: Laryngoscope with NBI system
19 Recruiting Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Conditions: Current Smoker;   Head and Neck Squamous Cell Carcinoma;   Hypopharyngeal Squamous Cell Carcinoma;   Laryngeal Squamous Cell Carcinoma;   Nasopharyngeal Carcinoma;   Oral Cavity Squamous Cell Carcinoma;   Oropharyngeal Squamous Cell Carcinoma
Interventions: Drug: Bupropion Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Nicotine Replacement;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Drug: Varenicline
20 Recruiting Multicentre, Randomized, Open-Label, Phase III Clinical Trial for Advanced Nasopharyngeal Carcinoma Patients
Condition: Nasopharyngeal Cancer
Interventions: Biological: autologous EBV specific Cytotoxic T Lymphocytes;   Drug: combination IV gemcitabine and IV carboplatin (AUC2)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years